Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05221645
Title Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (P+R-ICE)
Acronym P+R-ICE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southampton
Age Groups: adult | senior
Covered Countries GBR

No variant requirements are available.